Table I.

Demographic, clinical, and biochemical characteristics of the study patients.

Variable	Value
No. of patients, male/female	95/91
Age, y	46.4 (10.8); 35–60
Blood pressure, mm Hg
Systolic	124.7 (28.1); 98–162
Diastolic	79.1 (13.7); 60–110
Body mass index	25.2 (4.9); 20–30
Hemodialysis duration, y	7.3 (3.5); 3.8–10.8
Renal diagnosis, No. (%)
Hypertension	52 (28)
Chronic glomerulonephritis	31 (16)
Polycystic kidney disease	26 (14)
Interstitial nephritis	17 (10)
Other or unknown	60 (32)
Blood urea nitrogen, mg/dL	51.7 (13.5); 26–64
Creatinine, mg/dL	8.4 (2.5); 5.3–10.8
Glucose, mg/dL	88.1 (32.3); 60–113
Uric acid, mg/dL	6.0 (1.9); 3.7–8.0
Total cholesterol, mg/dL	185.7 (50.0); 96.0–267.0
Low-density lipoprotein cholesterol, mg/dL	97.9 (64.7); 80–130
Triglycerides, mg/dL	213.6 (198.9); 51.0–442.0
C-reactive protein, mg/dL	10.9 (10.1); 0–43
Insulin, IU/L	12.3 (11.4); 0.9–23.7
Hemoglobin, g/dL	11.4 (1.4); 8.3–12.8
Leukocyte count, 103/mL	7.4 (2.4); 3.5–9.8
Platelet count (/mL)	254.6 (74.2); 115–334
Kt/V, wk	1.96 (0.44)
Ejection fraction, %	48.7 (8.4); 20–60
Left ventricular internal dimension, mm	151.8 (41.6)
Left ventricular mass index, g/m2	137.6 (24.1); 113–163
HOMA-IR score	2.6 (1.8); (0.8–4.4)

Unless otherwise indicated, values are given as mean (SD); range.